SCOPUS 정보 검색 플랫폼

Volumn 33, Issue 4, 2005, Pages 277-282

Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration

(8) Poirier, Bertrand a Leparc Goffart, Isabelle a Crance, Jean Marc b Fleury, Hervé c Garin, Daniel b Gut, Jean Pierre d Tissier, Marie Hélène a Fuchs, Florence a

a AFSSAPS (France)

b Centre de Recherches du Service de Sante des Armees (France)

c BORDEAUX UNIVERSITY HOSPITAL (France)

d UNIVERSITY HOSPITAL OF STRASBOURG (France)

Author keywords

Anti vaccinia immunoglobulins (VIG); Anti vaccinia neutralizing antibodies; Proficiency testing study; Smallpox vaccine; Statistics

Indexed keywords

IMMUNOGLOBULIN; VACCINIA ANTIBODY;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HUMAN; PERFORMANCE; PRIORITY JOURNAL; SERODIAGNOSIS; SERUM; STATISTICAL ANALYSIS; VACCINIA VIRUS;

ANTIBODIES, VIRAL; EVALUATION STUDIES; FRANCE; HUMANS; LABORATORIES; NEUTRALIZATION TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SMALLPOX VACCINE; VACCINIA VIRUS;

VACCINIA; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 28544448338 PISSN: 10451056 EISSN: 10958320 Source Type: Journal
DOI: 10.1016/j.biologicals.2005.06.006 Document Type: Article

Times cited : (2)

References (6)

1
- 9644282950
- Standardization of a neutralizing anti-vaccinia antibodies titration method: An essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation
- I. Leparc-Goffart, B. Poirier, D. Garin, M.-H. Tissier, F. Fuchs, and J.-M. Crance Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation J Clin Virol 32 2005 47 52
- (2005) J Clin Virol , vol.32 , pp. 47-52
- Leparc-Goffart, I.¹ Poirier, B.² Garin, D.³ Tissier, M.-H.⁴ Fuchs, F.⁵ Crance, J.-M.⁶

2
- 28544439635
- PA/PH/PTS (2002) 12, DEF, Internal report, Council of Europe, Strasbourg;
- EDQM, European Department for the Quality of Medicines. Proficiency testing study: endotoxin content in vaccines for human use, PA/PH/PTS (2002) 12, DEF, Internal report, Council of Europe, Strasbourg; 2003.
- (2003) Proficiency Testing Study: Endotoxin Content in Vaccines for Human Use

3
- 28544439269
- 4th ed.
- European Pharmacopoeia Statistical analysis of results of biological assays and tests 4th ed. 2002 [chapter 5.3]
- (2002) Statistical Analysis of Results of Biological Assays and Tests
- Pharmacopoeia, E.¹

4
- 0141796316
- Duration of antiviral immunity after smallpox vaccination
- E. Hammarlund, M.W. Lewis, S.G. Hansen, L.I. Strelow, J.A. Nelson, and G.J. Sexton Duration of antiviral immunity after smallpox vaccination Nat Med 9 2003 1131 1137
- (2003) Nat Med , vol.9 , pp. 1131-1137
- Hammarlund, E.¹ Lewis, M.W.² Hansen, S.G.³ Strelow, L.I.⁴ Nelson, J.A.⁵ Sexton, G.J.⁶

5
- 0037171711
- Dose-related effects of smallpox vaccine
- S.E. Frey, F.K. Newman, J. Cruz, B. Shelton, J.M. Tennant, and T. Polach Dose-related effects of smallpox vaccine N Engl J Med 346 2002 1275 1280
- (2002) N Engl J Med , vol.346 , pp. 1275-1280
- Frey, S.E.¹ Newman, F.K.² Cruz, J.³ Shelton, B.⁴ Tennant, J.M.⁵ Polach, T.⁶

6
- 0037458734
- Smallpox vaccination and adverse reactions. Guidance for clinicians
- J. Cono, C.G. Casey, and D.M. Bell Smallpox vaccination and adverse reactions. Guidance for clinicians MMWR Recomm Rep 52 2003 1 28
- (2003) MMWR Recomm Rep , vol.52 , pp. 1-28
- Cono, J.¹ Casey, C.G.² Bell, D.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.